Literature DB >> 10782925

Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes.

D E Comings1, R Gade-Andavolu, N Gonzalez, S Wu, D Muhleman, H Blake, G Dietz, G Saucier, J P MacMurray.   

Abstract

The present study is based on the proposal that complex disorders resulting from the effects of multiple genes are best investigated by simultaneously examining multiple candidate genes in the same group of subjects. We have examined the effect of 20 genes for dopamine, serotonin, and noradrenergic metabolism on a quantitative score for attention deficit hyperactivity disorder (ADHD) in 336 unrelated Caucasian subjects. The genotypes of each gene were assigned a score from 0 to 2, based on results from the literature or studies in an independent set of subjects (literature-based scoring), or results based on analysis of variance for the sample (optimized gene scoring). Multivariate linear regression analysis with backward elimination was used to determine which genes contributed most to the phenotype for both coding methods. For optimized gene scoring, three dopamine genes contributed to 2.3% of the variance, p = 0.052; three serotonin genes contributed to 3%, p = 0.015; and six adrenergic genes contributed to 6.9%, p = 0.0006. For all genes combined, 12 genes contributed to 11.6% of the variance, p = 0.0001. These results indicate that the adrenergic genes play a greater role in ADHD than either the dopaminergic or serotonergic genes combined. The results using literature-based gene scoring were similar. An examination of two additional comorbid phenotypes, conduct disorder and oppositional defiant disorder (ODD), indicated they shared genes with ADHD. For ODD different genotypes of the same genes were often used. These results support the value of the simultaneous examination of multiple candidate genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10782925     DOI: 10.1034/j.1399-0004.2000.570304.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  22 in total

1.  Analysing the effect of candidate genes on complex traits: an application in multiple sclerosis.

Authors:  Tineke Hooper-van Veen; Johannes Berkhof; Chris H Polman; Bernard M J Uitdehaag
Journal:  Immunogenetics       Date:  2006-04-13       Impact factor: 2.846

2.  Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.

Authors:  B A Perry; K R Archer; Y Song; Y Ma; J K Green; F Elefteriou; K M Dahir
Journal:  Osteoporos Int       Date:  2016-02-29       Impact factor: 4.507

Review 3.  Dopamine genes and attention-deficit hyperactivity disorder: a review.

Authors:  Salvatore DiMaio; Nathalie Grizenko; Ridha Joober
Journal:  J Psychiatry Neurosci       Date:  2003-01       Impact factor: 6.186

Review 4.  Molecular genetics of attention deficit hyperactivity disorder.

Authors:  Stephen V Faraone; Eric Mick
Journal:  Psychiatr Clin North Am       Date:  2010-03

5.  Potential contribution of dopaminergic gene variants in ADHD core traits and co-morbidity: a study on eastern Indian probands.

Authors:  Subhamita Maitra; Kanyakumarika Sarkar; Paramita Ghosh; Arijit Karmakar; Animesh Bhattacharjee; Swagata Sinha; Kanchan Mukhopadhyay
Journal:  Cell Mol Neurobiol       Date:  2014-03-02       Impact factor: 5.046

Review 6.  Molecular genetics of attention-deficit/hyperactivity disorder: an overview.

Authors:  Tobias Banaschewski; Katja Becker; Susann Scherag; Barbara Franke; David Coghill
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-02-10       Impact factor: 4.785

Review 7.  The Good Behavior Game: a best practice candidate as a universal behavioral vaccine.

Authors:  Dennis D Embry
Journal:  Clin Child Fam Psychol Rev       Date:  2002-12

8.  Associations of the DRD2 TaqIA polymorphism with impulsivity and substance use: preliminary results from a clinical sample of adolescents.

Authors:  Christianne Esposito-Smythers; Anthony Spirito; Christie Rizzo; John E McGeary; Valerie S Knopik
Journal:  Pharmacol Biochem Behav       Date:  2009-04-01       Impact factor: 3.533

Review 9.  Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2007-07       Impact factor: 3.911

10.  Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria.

Authors:  G L Arnold; C J Vladutiu; C C Orlowski; E M Blakely; J DeLuca
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.